LINCOLN PHARMACEUTICALS
Back to Income Statement
|
LINCOLN PHARMACEUTICALS Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹100 Cr | ₹89 Cr | ₹95 Cr | ₹87 Cr | ₹66 Cr |
What is the latest Operating Profit of LINCOLN PHARMACEUTICALS ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹89 Cr |
| Mar2023 | ₹95 Cr |
| Mar2022 | ₹87 Cr |
| Mar2021 | ₹66 Cr |
How is Operating Profit of LINCOLN PHARMACEUTICALS Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹100 Cr | 12.00 | |
| Mar2024 | ₹89 Cr | -6.58 | |
| Mar2023 | ₹95 Cr | 9.52 | |
| Mar2022 | ₹87 Cr | 33.02 | |
| Mar2021 | ₹66 Cr | - | |
Compare Operating Profit of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,178.5 Cr | 1.5% | -4% | 7.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | 1.5% |
-4% |
7.3% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses